Search

Copyright:Beijing Yeeran Technology Co,Ltd.  京ICP备10004672号-3    By 300.cn Beijing

yirenheye

Related to PINGSENG
Related to development of molecular imaging in China

Ultrasound promotion plan
The Catalyst One Animal Biochemistry Analyzer is installed!
Harbin Medical University successfully installed the flying Enoch portable large mouse ultrasound!
The Catalyst One Animal Biochemistry Analyzer is installed!
Culex® animal automatic blood collection and drug perfusion system
The 15th FELASA Congress
YEERAN invite you to attend Expreimental Biology 2022 in Philadelphia, the United States
Vinno6 was used in the research published on the world top journal《Nature Biomedical Engineering 》

COMPANY  NEWS

INDUSTRY  NEWS

NEWEST  ACTIVITIES

On March 6, 2019, Beijing Novo Nordisk China's R&D Center announced that it would launch the INNOVO platform

Page view

On March 6, 2019, Beijing Novo Nordisk China's R&D Center announced that it would launch the INNOVO platform and cooperate with local innovation forces in the biomedical field to contribute actively to the innovation campaign aiming to accelerate the medicine and health development in Beijing.

In the meantime, it is YEERAN's honor and tremendous encouragement that its products and services have been acknowledged by leading pharmaceutical companies around the world.

We appreciate Novo Nordisk (China) Pharmaceutical Co., Ltd.'s trust for VINNO medical ultrasonography for small animals.

Novo Nordisk is a world's leading biopharmaceutical company that is committed to the health of human beings and benefiting patients, doctors, and society with advanced biotechnologies. Over the past 80 plus years, it has become a frontrunner in the diabetes treatment in the world with its unrivaled R&D strength.

Novo Nordisk (China) Pharmaceutical Co., Ltd. was established in 2994 and is the first biopharmaceutical that has established an R&D center in China.